{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:01:21Z","timestamp":1791507681319,"version":"4.3.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04214-6","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:06:57Z","timestamp":1781248017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Boerhaave\u2019s syndrome associated with glucagon-like peptide-1 receptor agonist use: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Jason M.","family":"Aubrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chance","family":"Benner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey T.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"4214_CR1","doi-asserted-by":"publisher","unstructured":"Liu QK. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists. Front Endocrinol. 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1431292.","DOI":"10.3389\/fendo.2024.1431292"},{"issue":"2","key":"4214_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/ph17020199","volume":"17","author":"WA Aldhaleei","year":"2024","unstructured":"Aldhaleei WA, Abegaz TM, Bhagavathula AS. Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort. Pharmaceuticals. 2024;17(2):199. https:\/\/doi.org\/10.3390\/ph17020199.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"4214_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.14309\/ajg.0000000000002777","volume":"119","author":"K Garza","year":"2024","unstructured":"Garza K, Aminpour E, Shah J, et al. Glucagon-Like Peptide-1 Receptor Agonists Increase Solid Gastric Residue Rates on Upper Endoscopy Especially in Patients With Complicated Diabetes: A Case-Control Study. Am J Gastroenterol. 2024;119(6):1081\u20138. https:\/\/doi.org\/10.14309\/ajg.0000000000002777.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4214_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/dom.14551","volume":"24","author":"S Wharton","year":"2022","unstructured":"Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4\u00a0mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94\u2013105. https:\/\/doi.org\/10.1111\/dom.14551.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"4214_CR5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/dom.12824","volume":"19","author":"K Bettge","year":"2017","unstructured":"Bettge K, Kahle M, Abd El Aziz MS, Meier JJ, Nauck MA. Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide\u20101 receptor agonists: A systematic analysis of published clinical trials. Diabetes Obes Metab. 2017;19(3):336\u201347. https:\/\/doi.org\/10.1111\/dom.12824.","journal-title":"Diabetes Obes Metab"},{"key":"4214_CR6","doi-asserted-by":"publisher","unstructured":"Chaudhry A, Gabriel B, Noor J, Jawad S, Challa SR. Tendency of Semaglutide to Induce Gastroparesis: A Case Report. Cureus Published online January. 2024;19. https:\/\/doi.org\/10.7759\/cureus.52564.","DOI":"10.7759\/cureus.52564"},{"issue":"12","key":"4214_CR7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.soard.2024.08.033","volume":"20","author":"TL Kindel","year":"2024","unstructured":"Kindel TL, Wang AY, Wadhwa A, et al. Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Obes Relat Dis. 2024;20(12):1183\u20136. https:\/\/doi.org\/10.1016\/j.soard.2024.08.033.","journal-title":"Surg Obes Relat Dis"},{"key":"4214_CR8","unstructured":"U.S. Food and Drug Administration. Semaglutide Injection (Label No. 209637s020s021). Published online 2023. Accessed July 18. 2025. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/209637s020s021lbl.pdf"},{"key":"4214_CR9","unstructured":"U.S. Food and Drug Administration. Wegovy (Semaglutide) Injection: FDA Approval Package and Labeling. Center for Drug Evaluation and Research (CDER); 2024. Accessed July 20, 2025. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2024\/215256Orig1s011.pdf"},{"issue":"11","key":"4214_CR10","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s10620-019-06028-0","volume":"65","author":"H Kuwano","year":"2020","unstructured":"Kuwano H, Yokobori T, Kumakura Y, et al. Pathophysiology of Vomiting and Esophageal Perforation in Boerhaave\u2019s Syndrome. Dig Dis Sci. 2020;65(11):3253\u20139. https:\/\/doi.org\/10.1007\/s10620-019-06028-0.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"4214_CR11","first-page":"526","volume":"8","author":"P Hindy","year":"2012","unstructured":"Hindy P, Hong J, Lam-Tsai Y, Gress F. A comprehensive review of esophageal stents. Gastroenterol Hepatol (N Y). 2012;8(8):526\u201334. PMID: 23293566; PMCID: PMC3533211.","journal-title":"Gastroenterol Hepatol (N Y)"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04214-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04214-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04214-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:58:53Z","timestamp":1787669933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04214-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4214"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04214-6","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Corewell health IRB reviewed the case and waived the need for IRB approval.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient gave consent for their case to be published.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient for publication of this case report.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"625"}}